后毒性帕金森症是多巴胺反应的后毒性帕金森症
Tina Liu1, J Eric Ahlskog1, James Bower1
1Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Journal of Parkinson's disease
|April 24, 2025
概括
后麻醉性帕金森症是一种罕见的缺氧缺血性脑损伤的疾病,可以通过多巴胺治疗来改善. 这一病例系列强调了五名患者,他们经历了多巴胺作用剂的症状缓解.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 临床医学 临床医学
背景情况:
- 帕金森症在缺氧-缺血性脑损伤后很少发生,特别是影响基底腺.
- 在这种情况下,多巴胺治疗的改善很少被报告.
研究的目的:
- 描述五名患有后麻醉性帕金森症的患者的临床和成像特征.
- 为了记录后毒性帕金森症对多巴胺治疗的反应.
主要方法:
- 使用梅奥诊所数据管理系统 (2000-2024) 进行了回顾性病例系列.
- 审查了患者数据,包括临床特征,神经成像 (MRI) 和药物试验 (多巴胺类药物).
主要成果:
- 在低氧事件后,确定了5名患有后厌氧帕金森症的患者.
- 所有患者都出现了帕金森症的症状 (勃拉迪基尼西亚,硬,震,姿势不稳定).
- 四名患者接受了carbidopa/levodopa,一名患者接受了多巴胺激动剂,所有患者在4年的中位数随访期间都显示了帕金森症的改善.
结论:
- 帕金森症是二次的缺氧-缺血性侮辱是不常见的.
- 这一病例系列表明,在患有后麻醉性帕金森症的患者中,多巴胺类疗法有显著的反应,这表明了潜在的治疗途径.
相关概念视频
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
181
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
181


